Abingdon Health Plc (AIM:ABDX)
London
· Delayed Price · Currency is GBP · Price in GBX 6.10
+0.10 (1.64%)
May 13, 2025, 4:35 PM GMT+1
Abingdon Health Income Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2018 - 2019 |
| Revenue | 6.82 | 6.14 | 4.05 | 2.84 | 11.62 | 5.24 | Upgrade
|
| Revenue Growth (YoY) | 27.60% | 51.67% | 42.68% | -75.60% | 121.93% | 129.88% | Upgrade
|
| Cost of Revenue | 3.23 | 2.46 | 1.97 | 6.43 | 7.48 | 1.15 | Upgrade
|
| Gross Profit | 3.59 | 3.68 | 2.08 | -3.59 | 4.14 | 4.09 | Upgrade
|
| Selling, General & Admin | 5.55 | 5.07 | 5.22 | 6.65 | 7.55 | 3.37 | Upgrade
|
| Other Operating Expenses | -0.11 | -0.26 | -0.25 | -0.24 | -0.15 | -0.13 | Upgrade
|
| Operating Expenses | 5.96 | 5.29 | 5.69 | 8.27 | 9.52 | 3.87 | Upgrade
|
| Operating Income | -2.37 | -1.61 | -3.61 | -11.87 | -5.37 | 0.22 | Upgrade
|
| Interest Expense | -0.06 | -0.05 | -0.07 | -0.07 | -0.23 | -0.07 | Upgrade
|
| Interest & Investment Income | 0.05 | 0.03 | 0.09 | 0 | - | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | 0.39 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -2.38 | -1.63 | -3.21 | -11.93 | -5.61 | 0.15 | Upgrade
|
| Merger & Restructuring Charges | 0.11 | - | -0.16 | -0.2 | -0.19 | - | Upgrade
|
| Impairment of Goodwill | - | - | - | -0.76 | - | -3.13 | Upgrade
|
| Asset Writedown | -0.36 | - | -0.09 | -6.43 | - | -0.4 | Upgrade
|
| Legal Settlements | - | - | - | -1.59 | - | - | Upgrade
|
| Other Unusual Items | -0.18 | 0.23 | -0.12 | -0.69 | -1.16 | - | Upgrade
|
| Pretax Income | -2.81 | -1.4 | -3.57 | -21.59 | -6.95 | -3.38 | Upgrade
|
| Income Tax Expense | -0.23 | -0.13 | -0.11 | -0.33 | 0.02 | -0 | Upgrade
|
| Net Income | -2.59 | -1.27 | -3.47 | -21.26 | -6.97 | -3.37 | Upgrade
|
| Net Income to Common | -2.59 | -1.27 | -3.47 | -21.26 | -6.97 | -3.37 | Upgrade
|
| Shares Outstanding (Basic) | 330 | 305 | 304 | 292 | 278 | - | Upgrade
|
| Shares Outstanding (Diluted) | 330 | 305 | 304 | 292 | 278 | - | Upgrade
|
| Shares Change (YoY) | 8.55% | 0.23% | 4.26% | 4.89% | - | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.00 | -0.01 | -0.07 | -0.03 | - | Upgrade
|
| EPS (Diluted) | -0.01 | -0.00 | -0.01 | -0.07 | -0.03 | - | Upgrade
|
| Free Cash Flow | -2.68 | -1.69 | 0.84 | -8.42 | -19.64 | 0.45 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | 0.00 | -0.03 | -0.07 | - | Upgrade
|
| Gross Margin | 52.57% | 59.97% | 51.30% | -126.70% | 35.66% | 78.05% | Upgrade
|
| Operating Margin | -34.80% | -26.18% | -89.27% | -418.52% | -46.24% | 4.15% | Upgrade
|
| Profit Margin | -37.94% | -20.72% | -85.76% | -749.98% | -60.02% | -64.45% | Upgrade
|
| Free Cash Flow Margin | -39.26% | -27.61% | 20.72% | -297.04% | -169.02% | 8.50% | Upgrade
|
| EBITDA | -2.03 | -1.25 | -2.98 | -10.59 | -4.94 | 0.28 | Upgrade
|
| EBITDA Margin | -29.83% | -20.36% | -73.75% | - | -42.54% | 5.31% | Upgrade
|
| D&A For EBITDA | 0.34 | 0.36 | 0.63 | 1.28 | 0.43 | 0.06 | Upgrade
|
| EBIT | -2.37 | -1.61 | -3.61 | -11.87 | -5.37 | 0.22 | Upgrade
|
| EBIT Margin | -34.80% | -26.18% | -89.27% | - | -46.24% | 4.15% | Upgrade
|
Updated Oct 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.